Clearline Capital LP Liva Nova PLC Transaction History

Clearline Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$48.6 - $57.12 $2.69 Million - $3.16 Million	-55,324 Reduced 9.97%	499,339 $27.9 Million
Q4 2023 Feb 14, 2024	BUY	$43.45 - $53.66 $4.31 Million - $5.33 Million	99,301 Added 21.81%	554,663 $28.7 Million
Q3 2023 Nov 14, 2023	SELL	$50.12 - $58.87 $5.01 Million - $5.88 Million	-99,950 Reduced 18.0%	455,362 $24.1 Million
Q1 2023 May 15, 2023	BUY	$40.84 - $58.14 $4.91 Million - $6.99 Million	120,251 Added 27.64%	555,312 $24.2 Million
Q4 2022 Feb 14, 2023	SELL	$43.88 - $56.16 $360,781 - $461,747	-8,222 Reduced 1.85%	435,061 $24.2 Million
Q3 2022 Nov 14, 2022	BUY	$48.37 - $66.5 $21.1 Million - $29 Million	436,279 Added 6229.0%	443,283 $22.5 Million
Q2 2022 Aug 15, 2022	BUY	$57.25 - $86.63 $400,979 - $606,756	7,004 New	7,004 $438,000

261

52.9M

316K

127K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.52B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

Stay updated on Clearline Capital LP with notifications on news.